The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

The supply of GLP-1 drugs like Ozempic has been increasing, but they’re still expensive for most patients. Here are answers ...

The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...

We came across a bullish thesis on The Cigna Group (CI) on Antonio Linares’ Substack. In this article, we will summarize the ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

Weight-loss drugs are already dropping in price; could they go even lower? - Consumers are now able to pay roughly $500 for ...

The lower out-of-pocket costs come at a time of governmental scrutiny on prescription drug prices ... Cigna Group (NYSE: CI) announced a first-of-its-kind pharmacy benefit offering that make ...

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy ... decline in the company's share price. Lars Fruergaard Jorgensen's ...

The massive pharmacy middlemen contend that Arkansas’ law, which requires PBMs to divest pharmacies they own in the state, ...

Congress is unlikely to codify the recent executive order to lower drug pricing as other US officials negotiate new prices, John Barkett, MBA, of Berkeley Research Group, explains. John Barkett ...

The Cigna Group, together with its subsidiaries ... for financing employer-paid future benefit obligations and stop loss insurance. The company distributes its products and services through ...